U.S. Office-based Labs Market Size, Share & Trends Analysis Report By Modality (Hybrid, Multi-specialty), By Service (Cardiac, Endovascular Intervention), By Specialist, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. Office-based Labs Market Growth & Trends
The U.S. office-based labs market size is expected to reach USD 18.3 billion by 2030 expanding at a CAGR of 7.46% over the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of vascular diseases and rising preference for minimally invasive procedures in outpatient settings are the major factors driving the demand for office-based labs (OBL) in the U.S. High prevalence of risk factors, such as smoking, high blood pressure, diabetes, and high cholesterol, along with the growing geriatric population, is expected to increase the incidence of Peripheral Artery Diseases (PADs).
The resultant surge in the number of procedures performed for their treatment is anticipated to fuel the market growth during the forecast period. The rapidly transitioning healthcare delivery scenario is driving key market players to transform their business models to achieve maximum benefit from ongoing transitions. A key driving factor supporting the changing preferences of consumers is the cost-effectiveness of OBL. Some of the key reasons to visit office-based labs are preventive care, underlying chronic condition, pre/post-surgery care, and injuries/trauma. In addition, high patient satisfaction with a focused and dedicated team of doctors is expected to boost the market in the U.S.
During the COVID-19 pandemic, private practices, such as OBLs, postponed elective procedures, which included elective angioplasty or elective rotational atherectomy during transcatheter aortic valve implantation, or any other elective vascular operations performed under general or peripheral anesthesia. According to the findings published by The Commonwealth Fund, in August 2020, the total number of ambulatory practices witnessed a decline of 60% and recorded a significant decline in provider office visits. Many OBLs in the U.S. have reported a sharp decline in their businesses, however, some of them are offering testing facilities and post-respiratory therapy.
U.S. Office-based Labs Market Report Highlights
U.S. Office-based Labs Market Growth & Trends
The U.S. office-based labs market size is expected to reach USD 18.3 billion by 2030 expanding at a CAGR of 7.46% over the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of vascular diseases and rising preference for minimally invasive procedures in outpatient settings are the major factors driving the demand for office-based labs (OBL) in the U.S. High prevalence of risk factors, such as smoking, high blood pressure, diabetes, and high cholesterol, along with the growing geriatric population, is expected to increase the incidence of Peripheral Artery Diseases (PADs).
The resultant surge in the number of procedures performed for their treatment is anticipated to fuel the market growth during the forecast period. The rapidly transitioning healthcare delivery scenario is driving key market players to transform their business models to achieve maximum benefit from ongoing transitions. A key driving factor supporting the changing preferences of consumers is the cost-effectiveness of OBL. Some of the key reasons to visit office-based labs are preventive care, underlying chronic condition, pre/post-surgery care, and injuries/trauma. In addition, high patient satisfaction with a focused and dedicated team of doctors is expected to boost the market in the U.S.
During the COVID-19 pandemic, private practices, such as OBLs, postponed elective procedures, which included elective angioplasty or elective rotational atherectomy during transcatheter aortic valve implantation, or any other elective vascular operations performed under general or peripheral anesthesia. According to the findings published by The Commonwealth Fund, in August 2020, the total number of ambulatory practices witnessed a decline of 60% and recorded a significant decline in provider office visits. Many OBLs in the U.S. have reported a sharp decline in their businesses, however, some of them are offering testing facilities and post-respiratory therapy.
U.S. Office-based Labs Market Report Highlights
- By modality, the single-specialty OBL segment dominated the market in 2021, and hybrid office-based labs are expected to record the fastest CAGR during the forecast period
- The adoption of digital health solutions, such as integrated care Electronic Health Records (EHRs) customized as per the care provider requirements is boosting the growth of multi-specialty labs
- In terms of services, vascular procedures are the most commonly performed procedures in OBL settings. Among vascular procedures, Peripheral Vascular Interventions (PVI) are the most common services being offered to patients
- In the specialist category, vascular surgeons are the leading service providers in OBL. All major vascular surgeries, such as aortic, mesenteric, renal, subclavian, iliofemoral, tibial, and pedal, are being performed by vascular surgeons in office settings
- In the U.S. almost 70% of surgical procedures are performed in outpatient settings, out of which, around 25% are performed in a physician’s office
- Mergers & and acquisitions, technological advancements, and new product launches are some of the strategies followed by major players. For Instance, in May 2021, Surgery Partners entered into a strategic partnership with UCI Health to develop & expand access to outpatient surgical facilities and enhance patient outcome
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Modality
2.2.2 Service
2.2.3 Specialist
2.3 Competitive Insights
CHAPTER 3 U.S. OFFICE-BASED LABS (OBLS) MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market
3.1.2 Related/Ancillary Market
3.2 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework & Reimbursement Scenario
3.2.1 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework
3.2.2 U.S. Office-Based Labs (OBLs) Market: Reimbursement Scenario
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing prevalence of target diseases
3.3.1.2 Preference for minimally invasive procedures
3.3.2 Market restraint analysis
3.3.2.1 High-risk option for severe cases
3.3.2.2 Lack of technical training for the MIS procedure
3.3.3 Industry Opportunities
3.3.3.1 Approval of endovascular procedures in office-based labs
3.3.3.2 Flexibility for physicians to convert to OBLs
3.4 Business Environment Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.1.1 Competitive rivalry: High
3.4.1.2 Threat of new entrants: Moderate
3.4.1.3 Bargaining power of buyers: Moderate
3.4.1.4 Bargaining power of suppliers: Moderate
3.4.1.5 Threat of substitutes: High
3.4.2 PESTLE Analysis
3.4.2.1 Political & legal landscape
3.4.2.2 Economic and social landscape
3.4.2.3 Technology landscape
3.5 Qualitative Analysis: Impact of COVID-19 on Office Based Labs (OBL)
3.6 U.S. Office-Based Labs (OBLs) Market: Penetration & Growth Prospect Mapping
CHAPTER 4 U.S. OFFICE-BASED LABS (OBLS) MARKET: MODALITY ANALYSIS
4.1 U.S. Office-based Labs (OBLs) Modality Market Share Analysis, 2021 & 2030
4.2 U.S. Office-Based Labs (OBLs) Modality Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Modality Segment
4.3.1 Single Specialty Labs
4.3.1.1 Single specialty labs market, 2017 - 2030 (USD Million)
4.3.2 Multi-Specialty Labs
4.3.2.1 Multi-specialty labs market, 2017 - 2030 (USD Million)
4.3.3 Hybrid Labs
4.3.3.1 Hybrid labs market, 2017 - 2030 (USD Million)
4.3.3.2 Qualitative analysis: Future trends of hybrid labs
CHAPTER 5 U.S. OFFICE-BASED LABS (OBLS) MARKET: SERVICE ANALYSIS
5.1 U.S. Office-Based Labs (OBLs) Market Service Market Share Analysis, 2021 & 2030
5.2 U.S. Office-Based Labs (OBLs) Market Service Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Services
5.3.1 Peripheral Vascular Intervention
5.3.1.1 Peripheral vascular intervention market, 2017 - 2030 (USD Million)
5.3.2 Cardiac
5.3.2.1 Cardiac market, 2017 - 2030 (USD Million)
5.3.3 Interventional Radiology
5.3.3.1 Interventional radiology market, 2017 - 2030 (USD Million)
5.3.4 Venous
5.3.4.1 Venous market, 2017 - 2030 (USD Million)
5.3.5 Endovascular Interventions
5.3.5.1 Endovascular interventions market, 2017 - 2030 (USD Million)
5.3.6 Others
5.3.6.1 Others market, 2017 - 2030 (USD Million)
CHAPTER 6 U.S. OFFICE-BASED LABS (OBLS) MARKET: SPECIALIST ANALYSIS
6.1 U.S. Office-Based Labs (OBLs) Market Specialist Market Share Analysis, 2021 & 2030
6.2 U.S. Office-Based Labs (OBLs) Market Specialist Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Specialist
6.3.1 Vascular Surgeons
6.3.1.1 Vascular surgeons market, 2017 - 2030 (USD Million)
6.3.2 Interventional Cardiologists
6.3.2.1 Interventional cardiologists market, 2017 - 2030 (USD Million)
6.3.3 Interventional Radiologists
6.3.3.1 Interventional radiologists market, 2017 - 2030 (USD Million)
6.3.4 Other Specialists
6.3.4.1 Other specialists market, 2017 - 2030 (USD Million)
CHAPTER 7 U.S. OFFICE-BASED LABS (OBLS) MARKET: REGIONAL ANALYSIS
7.1 U.S. Office-Based Labs (OBLs) Market, 2017-2030 (USD Million)
7.2 U.S Office-Based Labs (OBLs) Market: Top 5 States
7.2.1 Penetration Analysis: Top 5 states 2021
7.3 Pricing Analysis
7.3.1 Average cost of major procedures performed in Office-based labs
7.3.2 Average cost of major devices used in Office-based labs
7.3.3 Average cost of setting up an office-based labs
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Vendor Landscape
8.1.1 Partnerships
8.1.2 Marketing & promotions
8.2 Suppliers
8.2.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2.2 Company Competition Categorization
8.2.3 Company Market Position Analysis: Imaging Devices Manufacturer
8.2.4 Company Market Position Analysis: Vascular Intervention Devices
8.3 Service Providers
8.3.1 Company Market Position Analysis
8.4 Suppliers Company Profiles
8.4.1 Koninklijke Philips N.V
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.1.5 SWOT analysis
8.4.2 GE Healthcare
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.2.5 SWOT analysis
8.4.3 Siemens Healthineers AG
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.3.5 SWOT analysis
8.4.4 Medtronic PLC
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.4.5 SWOT analysis
8.4.5 Boston Scientific Corporation
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.5.5 SWOT analysis
8.4.6 Abbott
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.6.5 SWOT analysis
8.4.7 Cardiovascular Systems, Inc.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.7.5 SWOT analysis
8.5 Service Providers Company Profiles
8.5.1 Envision Healthcare Corporation
8.5.1.1 Company overview
8.5.1.2 Financial performance
8.5.1.3 Service benchmarking
8.5.1.4 Strategic initiatives
8.5.1.5 SWOT analysis
8.5.2 Surgical Care Affiliates (SCA)
8.5.2.1 Company overview
8.5.2.2 Financial performance
8.5.2.3 Service benchmarking
8.5.2.4 Strategic initiatives
8.5.2.5 SWOT analysis
8.5.3 Fresenius Medical Care
8.5.3.1 Company overview
8.5.3.2 Financial performance
8.5.3.3 Service benchmarking
8.5.3.4 SWOT analysis
8.5.4 Cardiovascular Coalition
8.5.4.1 Company overview
8.5.4.2 Service benchmarking
8.5.5 Surgery Partners
8.5.5.1 Company overview
8.5.5.2 Financial performance
8.5.5.3 Service benchmarking
8.5.5.4 Strategic Initiatives
8.5.5.5 SWOT analysis
8.5.6 TH Medical
8.5.6.1 Company overview
8.5.6.2 Financial performance
8.5.6.3 Service benchmarking
8.5.6.4 Strategic initiatives
8.5.6.5 SWOT analysis
CHAPTER 9 KOL COMMENTS & RECOMMENDATIONS
9.1 KOL Commentary
9.2 Recommendations
1.1 Market Segmentation & Scope
1.1.1 Regional Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Modality
2.2.2 Service
2.2.3 Specialist
2.3 Competitive Insights
CHAPTER 3 U.S. OFFICE-BASED LABS (OBLS) MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market
3.1.2 Related/Ancillary Market
3.2 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework & Reimbursement Scenario
3.2.1 U.S. Office-Based Labs (OBLs) Market: Regulatory Framework
3.2.2 U.S. Office-Based Labs (OBLs) Market: Reimbursement Scenario
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Increasing prevalence of target diseases
3.3.1.2 Preference for minimally invasive procedures
3.3.2 Market restraint analysis
3.3.2.1 High-risk option for severe cases
3.3.2.2 Lack of technical training for the MIS procedure
3.3.3 Industry Opportunities
3.3.3.1 Approval of endovascular procedures in office-based labs
3.3.3.2 Flexibility for physicians to convert to OBLs
3.4 Business Environment Analysis Tools
3.4.1 Porter’s five forces analysis
3.4.1.1 Competitive rivalry: High
3.4.1.2 Threat of new entrants: Moderate
3.4.1.3 Bargaining power of buyers: Moderate
3.4.1.4 Bargaining power of suppliers: Moderate
3.4.1.5 Threat of substitutes: High
3.4.2 PESTLE Analysis
3.4.2.1 Political & legal landscape
3.4.2.2 Economic and social landscape
3.4.2.3 Technology landscape
3.5 Qualitative Analysis: Impact of COVID-19 on Office Based Labs (OBL)
3.6 U.S. Office-Based Labs (OBLs) Market: Penetration & Growth Prospect Mapping
CHAPTER 4 U.S. OFFICE-BASED LABS (OBLS) MARKET: MODALITY ANALYSIS
4.1 U.S. Office-based Labs (OBLs) Modality Market Share Analysis, 2021 & 2030
4.2 U.S. Office-Based Labs (OBLs) Modality Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Modality Segment
4.3.1 Single Specialty Labs
4.3.1.1 Single specialty labs market, 2017 - 2030 (USD Million)
4.3.2 Multi-Specialty Labs
4.3.2.1 Multi-specialty labs market, 2017 - 2030 (USD Million)
4.3.3 Hybrid Labs
4.3.3.1 Hybrid labs market, 2017 - 2030 (USD Million)
4.3.3.2 Qualitative analysis: Future trends of hybrid labs
CHAPTER 5 U.S. OFFICE-BASED LABS (OBLS) MARKET: SERVICE ANALYSIS
5.1 U.S. Office-Based Labs (OBLs) Market Service Market Share Analysis, 2021 & 2030
5.2 U.S. Office-Based Labs (OBLs) Market Service Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Services
5.3.1 Peripheral Vascular Intervention
5.3.1.1 Peripheral vascular intervention market, 2017 - 2030 (USD Million)
5.3.2 Cardiac
5.3.2.1 Cardiac market, 2017 - 2030 (USD Million)
5.3.3 Interventional Radiology
5.3.3.1 Interventional radiology market, 2017 - 2030 (USD Million)
5.3.4 Venous
5.3.4.1 Venous market, 2017 - 2030 (USD Million)
5.3.5 Endovascular Interventions
5.3.5.1 Endovascular interventions market, 2017 - 2030 (USD Million)
5.3.6 Others
5.3.6.1 Others market, 2017 - 2030 (USD Million)
CHAPTER 6 U.S. OFFICE-BASED LABS (OBLS) MARKET: SPECIALIST ANALYSIS
6.1 U.S. Office-Based Labs (OBLs) Market Specialist Market Share Analysis, 2021 & 2030
6.2 U.S. Office-Based Labs (OBLs) Market Specialist Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Specialist
6.3.1 Vascular Surgeons
6.3.1.1 Vascular surgeons market, 2017 - 2030 (USD Million)
6.3.2 Interventional Cardiologists
6.3.2.1 Interventional cardiologists market, 2017 - 2030 (USD Million)
6.3.3 Interventional Radiologists
6.3.3.1 Interventional radiologists market, 2017 - 2030 (USD Million)
6.3.4 Other Specialists
6.3.4.1 Other specialists market, 2017 - 2030 (USD Million)
CHAPTER 7 U.S. OFFICE-BASED LABS (OBLS) MARKET: REGIONAL ANALYSIS
7.1 U.S. Office-Based Labs (OBLs) Market, 2017-2030 (USD Million)
7.2 U.S Office-Based Labs (OBLs) Market: Top 5 States
7.2.1 Penetration Analysis: Top 5 states 2021
7.3 Pricing Analysis
7.3.1 Average cost of major procedures performed in Office-based labs
7.3.2 Average cost of major devices used in Office-based labs
7.3.3 Average cost of setting up an office-based labs
CHAPTER 8 COMPETITIVE ANALYSIS
8.1 Vendor Landscape
8.1.1 Partnerships
8.1.2 Marketing & promotions
8.2 Suppliers
8.2.1 Recent Developments & Impact Analysis, by Key Market Participants
8.2.2 Company Competition Categorization
8.2.3 Company Market Position Analysis: Imaging Devices Manufacturer
8.2.4 Company Market Position Analysis: Vascular Intervention Devices
8.3 Service Providers
8.3.1 Company Market Position Analysis
8.4 Suppliers Company Profiles
8.4.1 Koninklijke Philips N.V
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.1.5 SWOT analysis
8.4.2 GE Healthcare
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.2.5 SWOT analysis
8.4.3 Siemens Healthineers AG
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.3.5 SWOT analysis
8.4.4 Medtronic PLC
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.4.5 SWOT analysis
8.4.5 Boston Scientific Corporation
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.5.5 SWOT analysis
8.4.6 Abbott
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.6.5 SWOT analysis
8.4.7 Cardiovascular Systems, Inc.
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.7.5 SWOT analysis
8.5 Service Providers Company Profiles
8.5.1 Envision Healthcare Corporation
8.5.1.1 Company overview
8.5.1.2 Financial performance
8.5.1.3 Service benchmarking
8.5.1.4 Strategic initiatives
8.5.1.5 SWOT analysis
8.5.2 Surgical Care Affiliates (SCA)
8.5.2.1 Company overview
8.5.2.2 Financial performance
8.5.2.3 Service benchmarking
8.5.2.4 Strategic initiatives
8.5.2.5 SWOT analysis
8.5.3 Fresenius Medical Care
8.5.3.1 Company overview
8.5.3.2 Financial performance
8.5.3.3 Service benchmarking
8.5.3.4 SWOT analysis
8.5.4 Cardiovascular Coalition
8.5.4.1 Company overview
8.5.4.2 Service benchmarking
8.5.5 Surgery Partners
8.5.5.1 Company overview
8.5.5.2 Financial performance
8.5.5.3 Service benchmarking
8.5.5.4 Strategic Initiatives
8.5.5.5 SWOT analysis
8.5.6 TH Medical
8.5.6.1 Company overview
8.5.6.2 Financial performance
8.5.6.3 Service benchmarking
8.5.6.4 Strategic initiatives
8.5.6.5 SWOT analysis
CHAPTER 9 KOL COMMENTS & RECOMMENDATIONS
9.1 KOL Commentary
9.2 Recommendations
LIST OF TABLES
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Procedure codes and physician reimbursement, 2021
Table 4 Shifting trends from the inpatient facility to the outpatient facility
Table 5 U.S. Office-Based Labs Market, by Modality, 2017 - 2030 (USD Million)
Table 6 U.S. Office-Based Labs Market, by Services, 2017 - 2030 (USD Million)
Table 7 U.S. Office-Based Labs Market, by Specialists, 2017 - 2030 (USD Million)
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Procedure codes and physician reimbursement, 2021
Table 4 Shifting trends from the inpatient facility to the outpatient facility
Table 5 U.S. Office-Based Labs Market, by Modality, 2017 - 2030 (USD Million)
Table 6 U.S. Office-Based Labs Market, by Services, 2017 - 2030 (USD Million)
Table 7 U.S. Office-Based Labs Market, by Specialists, 2017 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 U.S. Office-Based Labs (OBLs) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook, 2021 (USD Million)
Fig. 10 Market dynamics & trends analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 U.S. Office-Based Labs (OBLs) market: Penetration & growth prospect mapping
Fig. 14 U.S. Office-Based Labs (OBLs) modality market share analysis, (USD Million)
Fig. 15 U.S. Office-Based Labs (OBLs) modality market: Segment dashboard (USD Million)
Fig. 16 Single specialty labs market, 2017 - 2030 (USD Million)
Fig. 17 Multi-specialty labs market, 2017 - 2030 (USD Million)
Fig. 18 Hybrid labs market, 2017 - 2030 (USD Million)
Fig. 19 U.S. Office-Based Labs (OBLs) market service movement analysis, (USD Million)
Fig. 20 U.S. Office-Based Labs (OBLs) market service market: Segment dashboard (USD Million)
Fig. 21 Peripheral vascular intervention market, 2017 - 2030 (USD Million)
Fig. 22 Cardiac market, 2017 - 2030 (USD Million)
Fig. 23 Interventional radiology market, 2017 - 2030 (USD Million)
Fig. 24 Venous market, 2017 - 2030 (USD Million)
Fig. 25 Endovascular interventions market, 2017 - 2030 (USD Million)
Fig. 26 Other services market, 2017 - 2030 (USD Million)
Fig. 27 U.S. Office-Based Labs (OBLs) market specialist movement analysis, (USD Million)
Fig. 28 U.S. Office-Based Labs (OBLs) market specialist market: Segment dashboard (USD Million)
Fig. 29 Vascular surgeons market, 2017 - 2030 (USD Million)
Fig. 30 Interventional cardiologists market, 2017 - 2030 (USD Million)
Fig. 31 Interventional radiologists market, 2017 - 2030 (USD Million)
Fig. 32 Other specialists market, 2017 - 2030 (USD Million)
Fig. 33 Penetration analysis: Top 5 states 2021
Fig. 34 Recent developments & impact analysis, by key market participants
Fig. 35 Company competition categorization
Fig. 36 Company market position analysis (Imaging devices manufacturer)
Fig. 37 Company market position analysis (Vascular intervention devices)
Fig. 38 Company market position analysis: Service providers
Fig. 1 U.S. Office-Based Labs (OBLs) market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook, 2021 (USD Million)
Fig. 10 Market dynamics & trends analysis
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 U.S. Office-Based Labs (OBLs) market: Penetration & growth prospect mapping
Fig. 14 U.S. Office-Based Labs (OBLs) modality market share analysis, (USD Million)
Fig. 15 U.S. Office-Based Labs (OBLs) modality market: Segment dashboard (USD Million)
Fig. 16 Single specialty labs market, 2017 - 2030 (USD Million)
Fig. 17 Multi-specialty labs market, 2017 - 2030 (USD Million)
Fig. 18 Hybrid labs market, 2017 - 2030 (USD Million)
Fig. 19 U.S. Office-Based Labs (OBLs) market service movement analysis, (USD Million)
Fig. 20 U.S. Office-Based Labs (OBLs) market service market: Segment dashboard (USD Million)
Fig. 21 Peripheral vascular intervention market, 2017 - 2030 (USD Million)
Fig. 22 Cardiac market, 2017 - 2030 (USD Million)
Fig. 23 Interventional radiology market, 2017 - 2030 (USD Million)
Fig. 24 Venous market, 2017 - 2030 (USD Million)
Fig. 25 Endovascular interventions market, 2017 - 2030 (USD Million)
Fig. 26 Other services market, 2017 - 2030 (USD Million)
Fig. 27 U.S. Office-Based Labs (OBLs) market specialist movement analysis, (USD Million)
Fig. 28 U.S. Office-Based Labs (OBLs) market specialist market: Segment dashboard (USD Million)
Fig. 29 Vascular surgeons market, 2017 - 2030 (USD Million)
Fig. 30 Interventional cardiologists market, 2017 - 2030 (USD Million)
Fig. 31 Interventional radiologists market, 2017 - 2030 (USD Million)
Fig. 32 Other specialists market, 2017 - 2030 (USD Million)
Fig. 33 Penetration analysis: Top 5 states 2021
Fig. 34 Recent developments & impact analysis, by key market participants
Fig. 35 Company competition categorization
Fig. 36 Company market position analysis (Imaging devices manufacturer)
Fig. 37 Company market position analysis (Vascular intervention devices)
Fig. 38 Company market position analysis: Service providers
